Atmospheric Pressure and Epistaxis Relationship

July 29, 2024 updated by: Saglik Bilimleri Universitesi

Influence of Atmospheric Pressure on Patients Presenting to the Emergency Department With Epistaxis

In this study, investigators aim to understand the relationship between changes in atmospheric pressure and blood pressure, and to investigate whether these changes have an impact on the etiology of epistaxis.

Study Overview

Detailed Description

This study aims to investigate the potential effects of changes in atmospheric pressure on epistaxis and, if such effects exist, to review treatment adjustments based on weather forecasts for hypertensive patients to prevent potential hypertensive emergencies and enhance patient comfort. This research poses no risk to patients and is purely observational and clinical in nature.

The study will be conducted prospectively over a period of 6 months at the Emergency Department of Ankara Etlik City Hospital, focusing on patients presenting with epistaxis.After initial evaluation upon presentation to the emergency department, patients will undergo routine emergency department monitoring for epistaxis, including physical examination, vital sign monitoring, evaluation of coagulation parameters, and hemoglobin levels. Apart from routine tests, no additional invasive or non-invasive procedures will be performed by us.

Data obtained from patients and daily atmospheric pressure parameters will be evaluated and analyzed.

Study Type

Observational

Enrollment (Estimated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Yenimahalle
      • Ankara, Yenimahalle, Turkey, 06170
        • Recruiting
        • Etlik City Hospital
        • Contact:
        • Principal Investigator:
          • gulsen akcay, ass.prof.
        • Sub-Investigator:
          • Bedriye Muge SONMEZ, ass.prof
        • Contact:
        • Sub-Investigator:
          • mehmet ceylan, resident
        • Sub-Investigator:
          • gokce saygı uysal, specialist
        • Sub-Investigator:
          • semih toklu, resident
        • Sub-Investigator:
          • hakan dogan, specialist

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

patients over the age of 18 presenting to emergency department with epistaxis

Description

Inclusion Criteria:

Patients aged 18 and above Presenting to the emergency department with complaints of epistaxis, whether active or resolved.

Willing volunteers consenting to participate in the study. Residing in central districts of Ankara

Exclusion Criteria:

Patients under the age of 18. Pregnant individuals. Those with a history of maxillofacial surgery. Patients reporting a history of trauma at the time of admission. Patients stating they are from a city other than Ankara.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
epistaxis group
patients presenting to emergency department with epistaxis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
epistaxis
Time Frame: 24 hours
number of the patients with epistaxis will be evaluated accoridng to atmospheric preesure and wheather conditions on daily basis
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: gulsen akcay, ass. prof., ass. prof. of organization

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2024

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

July 17, 2024

First Submitted That Met QC Criteria

July 29, 2024

First Posted (Actual)

August 1, 2024

Study Record Updates

Last Update Posted (Actual)

August 1, 2024

Last Update Submitted That Met QC Criteria

July 29, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epistaxis Nosebleed

Subscribe